Salute e Benessere
Biosensors Market worth $54.37 billion by 2030 - Exclusive Report by MarketsandMarkets™
Wearable biosensors typically combine wearable electronics and biosensors. They are a recent advancement in healthcare technology, enabling monitoring of vital signs in patients, athletes, the elderly, children, including premature infants, and individuals needing long-term care. Additionally, these devices provide solutions for people in remote areas lacking access to healthcare and medical services. Noninvasive wearable biosensors integrate innovations into wearable electronics with compact biosensing technology. They are available as small, portable devices that can be worn on the body, integrated into clothing, or mounted on handheld equipment. Overall, wearable biosensors represent a significant development in healthcare technology.
Optical biosensors are commonly used to analyze biomolecular interactions. They can determine the affinity and kinetics of various molecular interactions in real time, without requiring a molecular tag or label. Optical sensors are used for several new applications, such as drug discovery, target identification, ligand fishing, assay development, and quality control. Their advantages include high specificity, sensitivity, small size, and cost-effectiveness compared to other technologies. Moreover, with the aid of nanotechnology, optical biosensors will become more superior in sensitivity. These are among the factors contributing to the high growth of the market for optical sensors during the forecast period.
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=798
North America held the largest share of the overall biosensors industry in 2030. PoC diagnostics is the fastest-growing application for biosensors in North America . The growth is attributed to the increase in the accessible patient population. According to the American Medical Association, the number of Americans suffering from chronic diseases was about 133 million in 2025, which is expected to reach 170 million by 2030. The rise in the waiver of Clinical Laboratory Improvement Amendments (CLIA) for specific point-of-care (PoC) diagnostic devices, such as coagulation, glucose monitoring, and hematology devices, further drives the growth of the biosensors market in North America . In North America , environmental changes are monitored through organized networks. Biosensors are adopted as environmental monitoring tools to assess soil, water, and air quality. Biodefense is another application contributing to this region's increasing demand for biosensors.
Key companies operating in the biosensors companies include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd ( Switzerland ), Medtronic ( Ireland ), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. ( Singapore ), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors ( Australia ), ACON Laboratories (US).
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=798
Semiconductor and Electronics Market Research Reports &Consulting
3D Printing Market by Offering (Printers, Materials, Software, Services), Technology [Fused Deposition Modeling (FDM), Stereolithography (SLA), Selective Laser Sintering (SLS)], Process, Application, Vertical - Global Forecast to 2030
UV Disinfection Equipment Market by UV Lamps (Mercury UV Lamps, UV LEDs), Reactor Chambers, Quartz Sleeves, Controller Units, Water and Wastewater Disinfection, Process Water Disinfection, Surface Disinfection, Air Disinfection - Global Forecast to 2030
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Web Site: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biosensors-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/biosensors.asp
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biosensors-market-worth-54-37-billion-by-2030---exclusive-report-by-marketsandmarkets-302499810.html